BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RPT1G readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RPT1G\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07107126-3028@assetmemo.bio
DTSTAMP:20261121T005445Z
DTSTART;VALUE=DATE:20281201
DTEND;VALUE=DATE:20281202
SUMMARY:RPT1G: Phase 1 readout est. (NCT07107126)
DESCRIPTION:RPT1G\, phase 1\, Acute Myeloid Leukemia.\nStudy: Safety and Pr
 oof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and Hi
 gh-Risk Myelodysplastic Syndromes\nEstimated primary completion: 1 Decembe
 r 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/rpt1g#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07107126
URL:https://assetmemo.bio/drug/rpt1g#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
